GYKI-52,466

GYKI-52,466

Names
IUPAC name 4-(8-methyl-9H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline
Identifiers
CAS Number	102771-26-6 Y 192065-56-8 (HCl salt) N
3D model (Jmol)	Interactive image
ChEBI	CHEBI:79560 N
ChEMBL	ChEMBL275006 N
ChemSpider	3417 N
ECHA InfoCard	100.162.378
IUPHAR/BPS	4210
KEGG	C15040 N
PubChem	3538
UNII	471V8NZ5X3 N
InChI InChI=1S/C17H15N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8H,6,9,18H2,1H3 N Key: LFBZZHVSGAHQPP-UHFFFAOYSA-N N InChI=1/C17H15N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8H,6,9,18H2,1H3 Key: LFBZZHVSGAHQPP-UHFFFAOYAH
SMILES CC1=NN=C(C2=CC3=C(C=C2C1)OCO3)C4=CC=C(C=C4)N
Properties
Chemical formula	C17H15N3O2
Molar mass	293.32 g/mol
Appearance	Yellow solid (HCl salt)
Density	1.393 g/cm3
Solubility in water	>10 mg/mL (HCl salt)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N  (what is YN ?)
Infobox references

GYKI-52466 is a 2,3-benzodiazepine that acts as an ionotropic glutamate receptor antagonist, which is a non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >> 50 μM for AMPA- , kainate- and NMDA-induced responses respectively), orally-active anticonvulsant, and skeletal muscle relaxant. Unlike conventional 1,4-benzodiazepines, GYKI-52466 and related 2,3-benzodiazepines do not act on GABA_A receptors. Like other AMPA receptor antagonists, GYKI-52466 has anticonvulsant and neuroprotective properties.